Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients
Clinical trial NCT03019003 · COMPLETED
Trial details
- NCT number
- NCT03019003
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2024-09-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.